AKT ligands and polynucleotides encoding AKT ligands
US7943732B2 · kind B2 · utility
13Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 5, 2007 |
| Grant date | May 17, 2011 |
| Priority date | — |
| Expiry date | Nov 24, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/60
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate AKT activity. The ligands, homopolyligands, and heteropolyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands, homopolyligands, and heteropolyligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.